IP Library Granted Patent US 8,895,287
Granted Patent B2
US 8,895,287 · App. 11/816,847 · Granted Nov 25, 2014

Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof

Inventors: Michael Katz (Malmö, SE); Hans Peter Smits (Holte, DK); Jochen Förster (Copenhagen, DK); Jens Bredal Nielsen (Charlottenlund, DK)
Assignee: Evolva SA
C12P7/42C12N9/0042C12N9/0073C12N9/1029C12N9/88C12N9/93C12N15/52C12P7/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,287
App. No.
11/816,847
Granted
Nov 25, 2014
Kind
B2
Abstract

A recombinant micro-organism producing resveratrol by a pathway in which phenylalanine ammonia lyase (PAL) produces trans-cinnamic acid from phenylalanine, cinnamate 4-hydroxylase (C4H) produces 4-coumaric acid from said trans-cinnamic acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA, or in which L-phenylalanine- or tyrosine-ammonia lyase (PAL/TAL) produces 4-coumaric acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA. The micro-organism may be a yeast, fungus or bacterium including Saccharomyces cerevisiae, E. coli, Lactococcus lactis, Aspergillus niger , or Aspergillus oryzae.

Claims (26)

1. An isolated or non-naturally occurring micro-organism, wherein the micro-organism has an engineered operative metabolic pathway producing resveratrol, or an oligomeric or glycosidically-bound derivative thereof, wherein the engineered operative metabolic pathway produces:

a) 4-coumaric acid from L-phenylalanine catalysed by a phenylalanine ammonia lyase and a cinnamate 4-hydroxylase expressed in the micro-organism or from tyrosine catalysed by a phenylalanine ammonia lyase or a tyrosine ammonia lyase expressed in said micro-organism; and

b) 4-coumaroyl-CoA from 4-coumaric acid catalysed by a 4-coumarate-CoA ligase expressed in said micro-organism;

wherein the micro-organism is cultured in a media with a carbon substrate and does not require an external source of phenylalanine, tyrosine, cinnamic acid or coumaric acid, and resveratrol is produced from the 4-coumaroyl-CoA by a resveratrol synthase expressed in the micro-organism.

2. The micro-organism as claimed in claim 1 , wherein said resveratrol is produced in a reaction catalysed by an enzyme in which endogenous malonyl-CoA is a substrate.

3. The micro-organism as claimed in claim 1 , wherein said resveratrol synthase is expressed in said micro-organism from a nucleic acid coding for said enzyme which is not native to the micro-organism.

4. The micro-organism as claimed in claim 1 , wherein said cinnamate 4-hydroxylase is expressed in said micro-organism from a nucleic acid coding for said enzyme which is not native to the micro-organism.

5. The micro-organism as claimed in claim 1 , wherein said phenylalanine ammonia lyase is expressed in said micro-organism from a nucleic acid coding for said enzyme which is not native to the micro-organism.

6. The micro-organism as claimed in claim 1 , wherein a native NADPH:cytochrome P450 reductase (CPR) is overexpressed in said micro-organism or wherein the micro-organism comprises a recombinant CPR.

7. The micro-organism as claimed in claim 1 , wherein at least one copy of a genetic sequence encoding the tyrosine ammonia lyase is operatively linked to an expression signal not natively associated with said genetic sequence in said organism.

8. The micro-organism as claimed in claim 1 , wherein at least one copy of a genetic sequence encoding the phenylalanine ammonia lyase is operatively linked to an expression signal not natively associated with said genetic sequence in said organism.

9. The micro-organism as claimed in claim 1 , wherein at least one copy of a genetic sequence encoding the cinnamate 4-hydroxylase is operatively linked to an expression signal not natively associated with said genetic sequence in said organism.

10. The micro-organism as claimed in claim 1 , wherein at least one copy of a genetic sequence encoding the 4-coumarate-CoA ligase is operatively linked to an expression signal not natively associated with said genetic sequence in said organism.

11. The micro-organism as claimed in claim 1 , wherein at least one copy of a genetic sequence encoding the resveratrol synthase is operatively linked to an expression signal not natively associated with said genetic sequence in said organism.

12. The micro-organism as claimed in claim 1 , containing one or more copies of an heterologous DNA sequence encoding phenylalanine ammonia lyase operatively associated with an expression signal, and containing one or more copies of an heterologous DNA sequence encoding cinnamate-4-hydroxylase operatively associated with an expression signal, and containing one or more copies of an heterologous DNA sequence encoding 4-coumarate CoA-ligase operatively associated with an expression signal, and containing one or more copies of an heterologous DNA sequence encoding resveratrol synthase operatively associated with an expression signal.

13. The micro-organism as claimed in claim 1 , lacking cinnamate-4-hydroxylase activity, and containing one or more copies of a heterologous DNA sequence encoding tyrosine ammonia lyase operatively associated with an expression signal, and containing one or more copies of an heterologous DNA sequence encoding 4-coumarate CoA-ligase operatively associated with an expression signal, and containing one or more copies of an heterologous DNA sequence encoding resveratrol synthase operatively associated with an expression signal.

14. The micro-organism of claim 1 , comprising expressible nucleotide sequences encoding, and said micro-organism is capable of producing, phenylalanine or tyrosine ammonia lyase, cinnamate 4-hydroxylase, 4-coumarate-CoA ligase and resveratrol synthase.

15. The micro-organism of claim 1 , wherein said 4-coumaric acid is produced from trans-cinnamic acid by cinnamate 4-hydroxylase, or said 4-coumaric acid is produced from tyrosine by phenylalanine ammonia lyase or tyrosine ammonia lyase, and 4-coumaroyl-CoA is formed in a reaction catalysed by an enzyme in which ATP and CoA are substrates and ADP is a product catalysed by 4-coumarate-CoA ligase.

16. The microorganism of claim 1 which is a bacterium.

17. The microorganism of claim 16 which is a bacterium belonging to a genus selected from the group consisting of Bacillus, Escherichia, Lactobacillus, Lactococcus, Corynebacterium, Acetobacter, Acinetobacter, and Pseudomonas.

18. The microorganism of claim 16 which is an Escherichia coli.

19. The microorganism of claim 1 which is a yeast belonging to a genus selected from the group consisting of Saccharomyces, Kluyveromyces, Pichia, Debaromyces, Hansenula, Pichia, Zygosaccharomyces and Schizosaccharomyces.

20. The microorganism of claim 1 which is a yeast belonging to the genus Saccharomyces.

21. The microorganism of claim 1 which is a Saccharomyces cerevisiae.

22. The microorganism of claim 1 which is a filamentous fungus belonging to a genus selected from the group consisting of Rhizopus, Fusidium, Gibberella , and Trichoderma.

23. The microorganism of claim 1 , wherein the micro-organism is capable of producing 0.44-0.53 μg of resveratrol per gram dry weight.

Assignments (3)
MERGER Recorded Jun 27, 2024
From: EVOLVA SA
To: DANSTAR FERMENT AG
Reel/Frame 067863/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2013
From: FLUXOME SCIENCES A/S
To: EVOLVA SA
Reel/Frame 029783/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2008
From: KATZ, MICHAEL; SMITS, HANS PETER; FORSTER, JOCHEN; NIELSEN, JENS BREDAL
To: FLUXOME SCIENCES A/S
Reel/Frame 020436/0170 →
Priority Claims (1)
GB 0503657.9 · Feb 22, 2005 · national
Continuity (1)
Related Publication 20080286844A1 · Nov 20, 2008